Roger Baxter

Best Publications

• Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

  Israel Lowy;Deborah C. Molrine;Brett A. Leav;Barbara M. Blair

  986
  Citations

• Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

  James J. Sejvar;Katrin S. Kohl;Jane Gidudu;Anthony Amato

  731
  Citations

• Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

  Nicola P. Klein;Joan Bartlett;Ali Rowhani-Rahbar;Bruce Fireman

  667
  Citations

• Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

  Steven Black;Henry Shinefield;Roger Baxter;Robert Austrian

  434
  Citations

• Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

  Nicola P. Klein;Bruce Fireman;W. Katherine Yih;Edwin Lewis

  391
  Citations

• Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

  Brett A. Leav;Barbara M. Blair;Mark Leney;Michael Knauber

  349
  Citations

• The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

  James Baggs;Julianne Gee;Edwin Lewis;Gabrielle Fowler

  335
  Citations

• Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

  Gary Thomas Ray;Jose Antonio Suaya;Roger Baxter

  326
  Citations

• Mycobacterial diseases and antitumour necrosis factor therapy in USA.

  KL Winthrop;R Baxter;L Liu;CD Varley

  318
  Citations

• Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias

  Bruce Fireman;Janelle Lee;Ned Lewis;Oliver Bembom

  277
  Citations

• The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

  Michael M. McNeil;Julianne Gee;Eric S. Weintraub;Edward A. Belongia

  252
  Citations

• Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.

  Arnd M. Herz;Tara L. Greenhow;Jay Alcantara;John Hansen

  250
  Citations

• Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

  Nicola P. Klein;Joan Bartlett;Bruce Fireman;Ali Rowhani-Rahbar

  246
  Citations

• Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

  Roger Baxter;Joan Bartlett;Bruce Fireman;Edwin Lewis

  228
  Citations

• Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

  Roger Baxter;Joan Bartlett;Bruce Fireman;Edwin Lewis

  228
  Citations

• Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection

  Sarah K. Browne;Rifat Zaman;Elizabeth P. Sampaio;Elizabeth P. Sampaio;Kamonwan Jutivorakool;Kamonwan Jutivorakool

  219
  Citations

• Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study

  Roger Baxter;Paula Ray;Trung N. Tran;Steve Black

  173
  Citations

• Waning Tdap Effectiveness in Adolescents.

  Nicola P Klein;Joan Bartlett;Bruce Fireman;Roger Baxter

  167
  Citations

• Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project

  Sharon K. Greene;Martin Kulldorff;Edwin M. Lewis;Rong Li

  157
  Citations

• Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents

  Lisa A. Jackson;Roger Baxter;Keith Reisinger;Annette Karsten

  145
  Citations